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We have examined the effect that microinjection of
a monoclonal antibody directed against human DNA
polymerase-a (SJK-287) has on DNA synthesis in exponentially growing human, mouse, and hamster cell
lines. We show that the SJK-287 antibody, when microinjected directly into the nuclei of cells is capable
of inhibiting DNA synthesis in all three cell lines
tested. Moreover, the effectivenesswith which this
antibody can inhibit ongoing DNA synthesis by the
microinjection assay is closely correlated with the ability of the antibody to neutralize DNA polymerase-a
activity fractionated from each cell linein vitro. Two
other monoclonal antibodies of the same class, one
directed against the cellular p53 protein (PAb122),
and one directed against the c-myc protein (PM-8)
were also tested for their ability to inhibit ongoing
DNA synthesis by direct microinjection and in lysolecithin permeabilized cells. Both monoclonal antibodies
failed to inhibit ongoing DNA synthesis in exponentially growing cellsby these assays.

DNA polymerase-a is the principal eukaryoticpolymerase
implicated in semi-conservative DNA replication (for review,
see Refs. 10 and 11).It is a general observation that growing
cells contain ahigh level of DNA polymerase-a that may
represent as much as 90% of the total cellular DNA polymerase activity (10). Biochemical inhibitors that can differentiate between purified polymerase-a, -p, and -y activities i n
vitro implicate polymerase-a insemi-conservative replication
of DNA in permeabilized cell systems (12-14) and inisolated
nuclei (15).
A panel of murine hybridoma cell lines which produce
monoclonal antibodies against human DNA polymerase-a has
been developed (16, 17). In vitro neutralization assays have
demonstrated that these antibodies arespecific and show no
cross-reactivity (asassessed by sensitive binding assays) with
DNA polymerase-@or -y(16). Moreover, some of these antibodies are capable of inhibiting DNA polymerase-a directed
nuclear DNA synthesis in a lysolecithin-permeabilized cell
system (18, 19).
We have examined the effect that microinjection of one of
these monoclonal antibodies designated SJK-287 has on DNA
synthesis in intactexponentially growing cellsfrom three
Numerous studies have demonstrated that microinjection different mammalian species. In addition, we have directly
of antibody molecules into mammaliancells in culture canbe compared the effect of the SJK-287 antibody and two other
used to investigate the role that the antigen, to which the monoclonal antibodies PAb122, directed against the p53 proantibodies are directed, has in theprocesses of cell prolifera- tein, and PM-8 directed against the c-myc protein on DNA
tion. This approach is based on the initial findings that: 1) synthesis by direct microinjection and by incubating these
antibodies can be microinjected into cells without apparent same antibodies withlysolecithin-permeabilized cells.
toxicity(1-9);
2) microinjected IgG antiSV40-Tantigen
EXPERIMENTAL PROCEDURES’
inhibits SV40-induced cell DNA synthesis (4, 6), and viral
replication (3);3) however, IgG anti SV40-T antigendoes not
RESULTS
inhibit serum-stimulated DNA synthesis (4,6); 4) control
IgG
microinjected into thenuclei of quiescent cells doesnot inhibit
Effect of Microinjected Antibodies on D N A Synthesisserum-stimulated DNA or RNA synthesis, or accumulation Recently studies of Miller et al. (18, 19) have demonstrated
(4-8). Amonoclonal antibody directed against the cellular that antibodies directed against human DNA polymerase-a
p53proteindesignated
PAb122, when microinjected into substantially inhibit nuclear synthesis in
cellswhich have
quiescent cells at or very near the timeof serum-stimulation been irreversibly permeabilizedby lysolecithin treatment. The
caninhibitentryintoS-phase
(5-7). However, thissame
degree to which DNA synthesis is inhibited in this system is
antibody when microinjected into S-phase cells does not in- proportional to the antibody concentration used. We examhibit ongoing DNA synthesis (5). This latter result prompted ined the effect that one of these anti-DNA polymerase-a
us to ask whether or not ongoing DNA synthesis could be monoclonal antibodies, SJK-287, and two other monoclonal
inhibited by antibody microinjection, when the monoclonal
antibody is directed against DNA polylmerase-a.
Portions of this paper (including “Experimental Procedures,”

* This work wassupported in part by National Institutes of Health
Grant 33694 to Dr. Renato Baserga (to L. K.) and by a Biomedical
Research Support Grant RR05417 (to W. E. M.). The costs of
publication of this article were defrayed in part by the payment of
page charges. This article must therefore be hereby marked “aduertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate
this fact.
ll To whom reprint requests should be addressed.

Tables I1 and 111, and Figs. 2-4) are presented in miniprint at the
end of this paper. The abbreviations used are: BHK, baby hamster
kidney; PBS, phosphate-buffered saline. Miniprint is easily read with
the aid of a standard magnifying glass. Full size photocopies are
available from the Journal of Biological Chemistry, 9650 Rockville
Pike, Bethesda, MD 20814. Request Document No. 86M-0056, cite
the authors, and include a check or money order for $3.60 per set of
photocopies. Full size photocopies are also included in the microfilm
edition of the Journal thatis available from Waverly Press.
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TABLE
I
Effect of microinjected antibodies onDNA synthesis in exponentially
growing cell lines
Exponentially growing human, hamster, and mouse cells were
microinjected with one of the
four antibodies listed above: mouse
monoclonal antibodies, anti-DNA polymerase-n (SJK-287); anti-p53
(PAb122);anti-myc(PM-8), or control mouse IgG.At 1 h after
microinjection, the cells were pulse-labeled for 30 min with 10 pCi/
ml ['Hlthymidine, fixed, and then processed for autoradiography as
described previously (5). The percentage of labeled cells was determined
by light microscopy after Giemsa"staining.
~.
~.
_ _ _ ~
~
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-~

Cell line/antibody
rnicroiniected

Fraction of labeled cells

"
"

microinjected/bockRround

."

Human (T98G)
SJK-28'7
PAb122
PM-8
IgGs
Hamster (tsAF8)
SJK-287
PAb122
PM-8
IgCs
Mouse (3T3)
SJK-287
PAb122
PM-8
IgGs ..
~

"
"

0.36
0.98

0.95
0.51
0.90
1.05
0.98

0.97

1.02

~

antibodies, PAb122 and PM-8 (directed against nuclear cell
cycle-dependent oncogene products), have onDNA synthesis
inexponentially growing human, hamster, and mouse cell
lines following direct nuclear microinjection. SJK-287 is a
mousemonoclonal antibodydirectedagainsthuman
DNA
FIG. 1. Photomicrograph of exponentially growing human
polymerase-cu developed by Tanaka et al. (16). This antibody
T98C cells microinjected with monoclonal antibodies: a,cell
inhibits DNA synthesis in lysolecithin-permeabilizedhuman microinjected with anti-p53 (PAb122); b, cells microinjected
uitro neutralizingactivity of with anti-DNA polymerase-a (SJK-287). Cells were microincells (18, 19) and exhibits in
polymerase-cu activity (16, 18).PAb122 is a monoclonal anti- jected with monoclonal antibodies as described. At 1 h after microinbody directed against the mousep53 protein developed by jection, the cellswere pulse-labeled with 10 pCi/ml of ["Hlthymidine
Gurney et al. (25). This antibody recognizes both mouse and for 30 min, fixed and processed for autoradiography. Magnification
humanp53nuclearprotein(7,
25, 27). PM-8 is a mouse is X400.
monoclonal antibodydirectedagainst bacteriallyproduced
human c-myc (28) protein and is capable of immunoprecipi- that the same antibody can inhibit nuclear DNA replication
tating a 65-kDprotein from a human leukemic cell line CCRF- in uitro, in lysolecithin-permeabilized human cells. That the
CEM (Fig. 4) and from phytohemagglutinin-stimulated hu- inhibition we observe following microinjection of SJK-287 is
man peripheral blood lymphocytes, but not from resting lym- not simply due to aspecific toxicity resulting from the introduction of antibodies tonuclear protein antigens, is suggested
phocytes.2
The resultsof these microinjection experiments are present by the observation that PAb122 and PM-8 antibodies (diin Table I. The fraction of labeled cells is presented as the rected against nuclear protein antigens) fail to inhibit DNA
synthesis (Table I and Fig. la); and, from our previous findratio of microinjected to backgroundcellsin these experiments to indicate therelative level of inhibition observed for ings that an antibody directed against RNA polymerase I
(another nuclear protein), does not inhibit DNA synthesis,
each cell line examined.
The data in Table I shows that antibody directed against but is capable of inhibiting nucleolar RNA synthesisand
DNA polymerase-a (SJK-287) when microinjected into the accumulation when microinjected into cells (9).
Time Course of Inhibition by Anti DNA Polymerase-a Annuclei of exponentially growing T98Gcells iscapable of
inhibiting DNA synthesis by 64%. In contrast, control non- tibody-While cells selectively permeabilized by lysolecithin
(PM-8),when exhibit acceptable preservation of gross structural integrity
immune IgG, anti-p53 (PAb122), or anti-c-myc
microinjected at roughly the same concentrationsas the anti and the capacity to carry out synthesis of DNA, RNA, and
DNA polymerase-a antibodies have very little if any, effect protein at near in uiuo rates for a short period of time (29on DNA synthesis in this cell line. Fig. 1, a and b, show 31); such cells are nonetheless irreversibly damaged and thus
autoradiographs of T98G cells microinjected with PAb122(a) the long range effect of antibodies in this system cannot be
ascertained. In order to determine the long range effect that
orSJK-287(b)antibodies.Fromthe
observeddecreasein
on replication in intact living
nuclear ["Hlthymidine labeling in Fig. Ib, it is apparent that the SJK-287 antibody has DNA
cells,
we
microinjected
this
antibody
into human T98G cells
the microinjected anti-DNA polymerase-a antibody is capable
of inhibiting nuclear DNA synthesis in uiuo. This confirms and examined itsaffect on the capacity of cells to synthesize
and extends the observationof Miller et al. (18) who showed DNA as a function of time after injection.
In these experiments T98G cells were microinjected with
* L. Kaczmarek, M. R. Miller, R. A. Hammond, and W. E. Mercer, SJK-287 antibody and at different times after injection the
cells were pulse-labeled with ["Hlthymidine, then processed
unpublished results.
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for autoradiography. The results of theseexperimentsare
However, when corrected for cellnumber, significantly higher
presented in Table I1 (Miniprint). The abilityof the SJK-287 levels of SJK-287 were required to inhibit DNA synthesisin
antibody to inhibit DNA synthesisdecreases with time after permeable T98G cells than reported (18, 19) for permeable
the initial microinjection. For example, T98G cells microin- HF cells (Fig. 3). The abilityof antibody SJK-287 to inhibit
jected with SJK-287 at time0 and pulse-labeled for 30 min at DNA polymerase-a activity extractedfrom T98G or H F cells
5 h after injection exhibit a 37% inhibition of DNA synthesis was therefore directly determined. When expressed as picomrelative to the 62% inhibition
observed when cellsare microin- oles of SJK-287/105 cells, approximately 9-fold higher conjected with the antibody, and thenpulse-labeled at 1 h after centrations of antibodySJK-287 were required toinhibit
DNA polymerase-a actvity from T98G cells than from H F
injection (Table 11).
In contrast, with cells microinjected at time 0 with SJK- cells. This is due to the fact that 9-10-fold higher levels of
287 antibody and pulse-labeled a t 20 h after injection, only polymerase-a were present in lo5 T98G cells than in lo5 H F
a n 18% inhibition of DNA synthesis is observed. These ex- cells. Essentially identical titration curves of antibody SJKperiments were repeated several times and gave essentially 287 were obtained for equal activities of polymerase-a from
the same results,suggesting that the inhibitionof DNA syn- T98G and HFcells (not shown). The higher levels of polymthesis observed in cellsmicroinjectedwith
SJK-287 is not erase-a in T98G cells appear to account for the higher consimply due toaspecific toxicity of the antibody preparation. centrations of antibodySJK-287 required to inhibit DNA
Effect of Anti DNA Polymerase-a Antibodies on D N A Po- synthesis inpermeable T98G cells than in permeable HF cells
lymerase from Different Mammalian Species-Previous re- (Fig. 3). As previously reported (19), much higher concentrasults have demonstrated the neutralizing activity
of SJK-287 tions of antibody SJK-287 were required to inhibit nuclear
permeablecells than were required to
antibody on DNA polymerase-a fractions prepared from hu- DNAsynthesisin
man diploid fibroblasts and from malignant human KB cell reduce polymerase-a activity extractedfrom the same number
line againstwhich the antibodywas initially directed(16, 18). of permeable cells. In contrast to studieswith permeable H F
Because little has been reported about the interspecies reac- cells which are quite consistent, the amount of inhibition of
tivity of this antibody, we thought it would be worthwhile to DNA synthesis in permeable T98G cells by antibody SJK287 was more variable. This variability is reflected in several
test its neutralizing effect on DNA polymerase-a activity in
points in Fig. 3 (Miniprint) which are not on the titration
comparative experiments with crude DNA polymerase-a fractions prepared from each line. The results of these experi- curve. In several experiments, very little inhibition of DNA
ments are shownin Fig. 2 (Miniprint). The data presented in synthesis by even high concentrations of SJK-287 was obFig. 2 shows that the SJK-287 antibody is able to neutralize served. The reason for this variability in permeable T98G
crudeDNApolymerase-afractionsprepared
from human, cells is not yet known. Antibodies directed against proteins
hamster, andmouse cells in a concentration-dependent man- p53 or c-myc had little, if any, effect on DNA synthesis in
ner. The neutralizing titer of the SJK-287 antibody for the permeable T98G or HF cells.
DNA polymerase activities from different species is given in
DISCUSSION
the legend of Fig. 2 (Miniprint). From the data presented, it
is clear that the
effective antibody titer required to neutralize
In this paper,we have examined the ability
of a monoclonal
50% of the DNA polymerase-a activity mouse
in
and hamster antibody (SJK-287) directed against human DNA polymercells is considerably higher than that required to neutralize ase-a (16) to inhibit ongoing DNA synthesis when directly
an equivalent activityof DNA polymerase-a in humancells.
microinjected into the nuclei of exponentially growing cells
Species Specificity of Microinjected Anti-DNA Polymerase- fromthreedifferentmammalian
species. Inaddition, two
a Antibody-In order to determine whether the
decreased other monoclonal antibodies of the same class, and directed
ability of antibody SJK-287 to neutralize
mouse and hamster against the cell-cycle dependent p53 (27, 32, 33) and c-myc
DNA polymerase-a activities in vitro (relative to human po- (34-36) oncogene products were also examined for their ability
lymerase-a) also occurs in vivo, an equivalent concentration to inhibit ongoing DNA synthesis by the microinjection, and
of SJK-287antibody wasmicroinjected into the nuclei of by the lysolecithin permeabilized cell assays (18, 19).
exponentially growing human,hamster,and
mouse cells.
The novel findings in this paper are: 1) by direct nuclear
Anti-p53 antibody (PAb122) and anti-myc antibody (PM-8)
microinjection into intact living cells, the SJK-287 antibody
were also microinjected, in this study. The results are sumcan efficiently inhibit ongoing DNA synthesis in human, and
marized in Table I. The SJK-287 antibody appears to more albeit to a lesser degree, in mouse and hamster cells as well;
efficiently inibit DNA synthesis in humancells than in ham- 2) by comparative in vitro neutralizationassays ahigher
ster or mouse cell lines. These experiments were repeated at antibody concentrationis required to neutralize an equivalent
least twice with similar results. The i n vitro neutralization amounts of polymerase-a activity fractionated from mouse
and hamster cell lines than from human cells; 3) in exponenresults presented in Fig. 2 (Miniprint) agree well with the
tially growing human cells, when assayed by direct nuclear
observed efficiency of in vivo inhibition of DNA synthesis
following microinjection of the SJK-287 antibody into each microinjection or when incubated with lysolecithin-permeabilized cells, neither PAb122 nor PM-8monoclonal antibodies
cellline. The data also indicatesthatantibodiesdirected
against p53 or c-myc proteins have little, if any, effect on are able to inhibitongoing DNA synthesis.
The SJK-287 antibody haspreviously been shown to neuDNA synthesis in S-phasecells.
in vitro (16, 18) and is
Effect of D N A Polymerase-a Antibodies on DNA Synthesis tralize DNA polymerase-a activity
in Permeable Cells-We also wanted to directly compare the capable of inhibiting DNA synthesis in certain lysolecithineffects of microinjected antibody SJK-287 on DNA synthesis permeabilized human cells (18,19). By immunocytochemistry
in viable cells with itseffects on DNA synthesis in
permeable most, if not all, of the polymerase-a molecules have been
localized to thenucleus of growing cells, but are not detectable
cells.
T98G cells were therefore permeabilized with lysolecithin by this method in nonproliferating cells (17). Although our
and theeffects of SJK-287 on DNA synthesis
was determined. microinjection results for human T98G cells with SJK-287
arenotintrinsicallysurprising,
especially in viewof the
Fig. 3 (Miniprint) shows that SJK-287 inhibited DNA synthesis in permeable T98G cells in a dose-dependent manner. previous results with other permeabilized human cells (18,
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where anti-p53 antibodies inhibit or a t least delay entry into
The microinjection assay utilizes intact living cells; and S-phase havefailed.3
Monoclonal antibodies, because of their high specificity of
therefore, it was not predictable a priori that the SJK-287
antibody would have the same effect on DNA synthesis in. action can be used as specific inhibitors of target molecules;
gainfully employed to study therole of these
uiuo as have previously been demonstrated in the permeabil- and thus, can be
target
molecules
inthe processes of cell proliferation. In
ized cell system (18, 19). That is, it is not predictable that
molecules directly
active nuclear polymerase-a molecules (17) engaged in semi- addition t o being able to introduce antibody
into
the
nucleus
of
living
cells,
the
microinjection
assay allows
conservative chromosomal DNA synthesis in uiuo would be
to growing
one
to
study
some
processes
such
as
the
resting
fully assessable to the inhibitory action
of this antibody. This
is especially true in view of current concepts of a putative transition of cells, which does not occur in irreversibly perbiochemical studies
organized multienzyme replication complexcomposed of a meabilized cell systems. In contrast, some
which canbe performedin the permeabilized cell system
number of interacting protein components(37-39). However,
cannot be performed onmicroinjected cells.
our results clearly show that the SJK-287 antibody caneffiFor instance, incorporation of radioactive precursors into
ciently inhibit ongoing DNA synthesis when microinjected
macromolecules can be readily quantitated by liquid scintilinto intactliving cells (Table I).
lation countingin permeabilized cells, but autoradiography or
Our finding that the SJK-287 antibody can also neutralize microphotometry must beemployed in microinjection studies
polymerase-a activity in uitro and inhibit ongoing DNA syn- (5-8). Moreover, in permeabilized cells by “pulse/chase” exthesis in uiuo in mouse and hamster cells lines is of interest. periments we have recentlyshown that the SJK-287 antibody
This is to our
knowledge, the first report
of interspecies cross- inhibits both the synthesis and the maturation
of Okazaki
reactivity of this particular monoclonal antibody; however, DNA (19); such studies cannotbe performed in microinjected
Wang et al. (40) have recently reported on the
species-specific cells. Finally, our work suggests that the direct nuclear miinteraction of other anti-polymerase-a antibodies. It is note- croinjection assay coupled with the permeabilized cell assay
worthy that the results of our comparative in uitro neutrali- may be useful to distinguishbetween nuclear protein antigens
zation assays show that a higher concentration of SJK-287 is critically important to the immediate
process of ongoing semirequired t o neutralize a n equivalent amount of polymerase-a conservative DNA synthesis from those more closely associactivity fractionated from mouse and hamster cell lines than ated with cell-cycle progression into S-phase (41, 42).
from human cell lines.
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were
to inrmnoprecipitate e53and myc proteins f r m hcells. m he
tested for their ability
p r d u r e for inmumprecipitation
and polyacrylamidegel dectrcphoresis in100 slab gels
has been described in detal1 1271
The h m cell line c c w a XBP used to prepare
C3'81 "ethionine 11063.6ci/ ml;, ~ e England
v
Nuclear corp. -ton,
ml labeled protein
eXtract8 for inrmnoprecipitation.The results of these
e
x
p
c
h
t
s are shasl in pig. 4.
miniprint. By imMncpercnidase stainingas dffribed previously 1271 bth PAb 122 and
PM-8 m m l 0 ~ antibodies
1
raognize antigenic determimats in h~ 9 %cells hich are
lwlized prinarily within the
nw1( m t n h ) .
lhkxlonal antibodies

bv

In Vitro

m l m a s e "Assaw and Antibody t&utralizations:

The STK-287 antibody preparationsused for microinjection
were ala0 tested for their
stivity
in protein fractims prepared
ability to neutralize m p o l m - - o
fron hman, hanster and -e
cell lines. These assays and the preparation of
OWL
(16,181.
I"
~0lyerase-ofractians were p e r f a d a8 previously described in detail
these V h t s , identical a m m t s of rn plyerase-o Mivity -e
incubated with
different mncentrations of antibody60 minutes
for
at O T , and then p1-m
activity
Y I S determined as desribed (XI. The results are shaa in Fig. 2 miniprint.
Cell Pemmablization and OWL %thesis
Cell lines and culture d t i o n s :

Syrian h t e r tsAp8 cells were m i n t a i d in hrlbecm's d i m mntaining 100 &nor
calf sennn at 34'C 120, 211. Ts AF8 cells are a G1"ific t-ature
sensitive cell
cycle outant of!+$?cells
x
originally isolated
by -stin
et al. 1221. The ts pr-ty
of
this mhant xas m t used in this stwly. swiss
3 3 muse cella were maintained at37-c in
hrlbecm's d i m mntaining 100 fetal calf
s
e
- as described previously 151. T98G
h m glloblastara cell6 1231 were maintained inEarle's minim1 essential d i m
containing vitaminsand 100 fetal calfs
e
- at 37'c. Hs24F IHF) h m diploid
fitnoblasts 118) were m i n t a i d in 450 Dulbecco's d i m , 450 H a n ' s F-10 d i m with 100
fetal calf8em at 3 7 F . "ancells, derived f m peripheral bled of a patient
lakemi=were m i n t a i d in WMI 1640 d i m mntaining 100
with acute lynphoblastic
fetal calfe m at 37-C as previously described1271.

m
o
ln
a
l Antibodies:
The STK-287 antibody is
a rimuse mmlonal antibody 1 1 s 281 &
e
l
- by Tanalca et
al., I161 and is d i r d against hrnanrn polyerases The PAbl22 m m l o ~ antibody
l
(Is11 &
v
e
l
&
by Gurney et al. (251 is directed against
mxlse p53 protein, but
ala0
r-nizes
" n t s
on h m (but not hamster) p53 proteins
17, 25,271.
The
isa muse m m l d antibody I I s 3 1 directed againsta
cprotein 1281. FU-8 a b a kid gift ofDr. G. Rover=
bacterially-prooduced hIwistar Institute ofR
n
a
W and Biolosy. Philadelphia, Pa.)
All m m 1 0 ~ antibodies,
1
and m n t r o l nonimmme muse I s ' s uaed in thisstdy were prepared as previously
desribed ( 7 ) .
FU-8 antibody

Microinjection

msays:

PIotcM1s for permaabilizing cells with lysolecithin
and m u r i n g rn replication
have been described in detail
118,19). Results are -ressed
as 0 inhibition ofOWL
synthesis by anti OWL plyerase-mantibody, relative to control antibody, as a fmtion
of antibody m-tration per 105 cells. This facilitated -ison
of the effect of
permsable cellsand OWL pol-ase-cactivity
i n .
antibodies on OWL replication in
The results are shasl in Fig.3 miniprint.
In this 8tu3y S a m differences were abserved in the efficiency with rhich the
STK-287 antibody inhibitedOWL synthesis by microinjection e
d
to that abserved h e n
r e s incubated withw i l i z e d cells. Microinjectian ofthe SJK-287
the antibody
rn synthesis by 62-700 in -tially
growing T98G
antibody efficiently inhibited
cells (Table 1. text and Table I1 and 111. miniprint); vhereas I" the
permaabilired cell system, the STK-287 antibody minally redu%d OWL aynulesis incells
by only 10-450 (Fig 3 miniprint).
he differ- in
the efficiency with which the
"287
antibody inhibited ongoing
OWL synthesis by the direct nicroinjgticn assay
relative to the permsabilized cell assay
can m t be attriblted to a limited mncentration
of anti- in the latter assay. At high antibody carentraticns
(50 v g of SJK-287 in a
50 ul voltme), if nucleiare freely -le
to the antibody, 106 permaable cell nuclei
wuld
m t a i n- 0 . 5 ug of STK-287, aich is mre antibody than can be microinjected into
the nvlei of cells;and thus, shouldprwide a greater reduction of OWL eymthsis.
Therefore, microinjection w
s to be mre efficient than the penneabilized c e l l
system. htst likely, this ia todue
the fact that antibody
mlecules are directly
of cells by the microinjection t
e
c
h
n
q
iu
e
; and thus, the
introduced into the nuclei
m l e a r e a n e dDes mt pose a barrier to the antibodies.as it dDes in prmabilired
cells (19).

pr-e:

The glass-ilky microin3ection prmedures deyeloped by G r a e s m and G r a e s m
(241 with thedification for antibody microinjection described
by us (7.8.91 -6 used
to introduce m m l o d antitdies lor c ~ t r o antibodies)
l
directly into the nuclei of
SJK-287 antibody
exponentially gravlng cells. We first determined the effect that the
has on rn synthesis inhT98G cells at different times after initial microinjection
lnBm I1
microiniected withSTK-287 antibody pr-ation and at
of the antibody. T98G cells -e
different &e
after injectionthe cells-werepulselabeled for30 miiutes with 1 0 ~
Tine mure Of inhibition of
D m synthesis in exFmentially
gravlng T98G cells
by
Ci/ml of1383 thyvidine ( 6 . 7 Ci/mle; New England Nuclear Cop. Bxltcn, ml,
microinjected STK-287 antibody
three times inm'kdamx salt mlution, fixed in~ethaMl,and subsequently
processed for autoradiography
acmrding to itmdard prmedures. The perc&tage-of
labeled cella xas determined by light microsccpy after Gi- staining. The SJK-287
e
n microinjected into TPBG
cells efficiently inhibitsrn synthesis and the
antibody h
magnitude of inhibition
decreases with tire (Table
11, miniprint). These expc-ts
Tinelabelling
Of Fraction
of
[ % I thpidine
were repeated several times with essentially
similar results. In all expecinents, the
microinjection
after
labeled cells
0 Inhibition
m
i
m
m inhibition ofLW. synthesis 18s
observed when cells e r e labeled at 1 hr
post-injection.

=shed

In all subsqwnt experhems,
cells were microinjected withthe antibodies under
study and labeled at 1 m. after injection. By this procedure
one is m u r i n g the
effect that microinjected antibodies
have on w i n g rn synthesis in
S
cells,
rather than the effecton cell cycle prqression f r m a resting to gravlng stage 1 7 ) .
T a b l e I11 (mini print1shous the results of dilution
e x p e r h t s using the SJK-287
antibody, The initial m-tration of the STK-278 antibody IBE 5 ng of protein/ml of
1500-00011 as
solotion as determined by protein assay (Bio-Rad protein assay kit,
described by the mufacturers. The results shar that a 1:lO dilution lO.hg/mll of
STK-278 is stillcapable of inhibitingONIL synthesis by 290; m e r , at a 1:lOO dilution
120. Ths a m m t of
10.05 rqs/mll the inhibitionobeerved after microinjection is only
ralution thatcan be delivered to intact viablecells using the glass-illary
n
e
w is
hghd, m e can calmlate
abut 1 x 10-1l ml/nucleus 1241. At a protein m-tration of
that appraxhtely 0 . 0 5 ~of I s CM be delivered to each nucleus. In T98G cells, this
armylt is sufficient
to inhibit OWL synthesis ~cnpletelyin m s t injected cells1figure 1, text).

(hrl

cmicroinjected/kkqrordI

1

0.38

62

3

0.57
0.63
0.82

18

5
20

i3

37

T98G cells were plated at 5x104 cella/6h petri dishin cultured i m and
microinjected at2 day afterplating. The SJK-287 antibody res microinjected at tine
z a o and the cells
were pulse-labeled far30 minutes at the times indicated
amve and
subsequently fixed
and pro~eesedfor autoradiography. The nlnnber of labeledcells in
on the same -slip
m?,
mcroinjected and tackgram3 (no" microinjected) cells gr-ng
determined by light micro-y
(see Fig. 1. text)

Microinjection of Monoclonal Antibodies

10807

E f f e t of a n t i k d y d i l u t i o n on the a b i l i t y o f SJK-287 to i n h i b i t OWL synthesis in T98G

cells

R a c t i o n of [%I thpidine
lateled cells
(Fnicminjetedihckgraud)

Antitcdy dilution

m

0.30
0.60
0.71

UlX3iluted
1: 1
1: 10
1: 100
1: 1000

S Inhibition

40
29
12
05

0.88

0.95

&kccclonal a n t i m y YK-287 was p r e p ~ e dat a p r o t e i n m m t r a t i o n of %Ad as
&scribed by W e e r et
(7). U d l u t e d preparations. or pr-ations
diluted in PES
were microinjeaed into exponentially graring T98G cells. The cells -e
labeled with
[%I thymidine 85 d e r r i b e d i n (Table I, text)

al.

ug MAB I m l
Pig. 2.

Neutralizaticn
of
polyner-o
a c t i v i t y by mnrrlonal antitcdy (ml
YK-287. Neutralization t i t r a t i m -e
p e r f o d as described (16,181 using
m e unit of OWL p l - a s e o
prepared f r m d i f f e r e n t cells lines. (A I ,
h m T98G: C 0 I harmter, tsAF8; I 0 I , mx?e 3 3 . The a n t i k d y titer
( u g h 1 s u f f i c i e n t to neutralize one unit of m4 pol-ase-o
a c t i v i t y by 50% is
0.03 for h m T98G. 0.5 for harmter tsRP8. and 3.5 f o r m
5
e 3T3 cells.
respectively.
BO I

70

t

/

Lop p o l e IqGAO’ Cells

Pig. 3

Tk e f f e t of antikcdy SJK-287 m OWL p o l y n e r e a a c t i v i t y and m
replication in HF cells and ~ 9 8 Gcells. m plynerase-o (frerrion 1) ces
prepared f r m HF and T98G cells as d e r r i b e d , and the a b i l i t y of d i f f e r e n t

mmentrations of SJK-287 to i n h i b i t m pl”
a c t i v i t y ces determined.
Results are expressedas % inhibition of ONA plyrerase-o. a c t i v i t y extracted
f r m lo5 cells ( r e l a t i v e to m n t r o l s assayed i n the absence of antL.todies) as
a function of antikdy mncentration; i.e., 10s (-le
STK-287/105 cells.) w
plynerasea I I i T99: plynerase-o ( o
For ONA synthesis studies, 4 1 s
were p n m a b i l i z e d w i t h l y s o l e i t h i n and p r e i M b a t e d w i t h d i f f e r e n t
mrrentratiof a n t i k d y SJK-287. Tbe incorporation of I 3 1 TCP i n t o m was
determined as described (18). Results are expressed as % inhibition of m
synthesis in 105 -le
cells as a function of antikdy comentration:
YK-287/105 cells). HF OWL synthesis ( A I frm pr-iwsly
i.e., log I-le
rep~ctedstudies 118) and d e t e r m i d i n this study I, I: T98G ONA synthesis
I A I . OWL synthesis in permeable HF and T98; cells vas inhibited
5% by high
m n l e n t r a t i O N of a n t i p53 and a n t i qc a n t i t d i e s (data mt s M ) .

).

-

and E= n
o
& mn&e I-.
lblgular e i g h t narkeri’are indicated by
b r i z o n t a l ‘ l i n e s and are, f r m top totton. b i n e sem albmrin I69.0001 and
ovalhnnin (46.000).

